Literature DB >> 1452517

Cancer cell procoagulants and their implications.

S G Gordon1.   

Abstract

Cancer cells induce abnormal blood coagulation through a process that probably involves a combination of increased activators and deficiencies of anticoagulants. The probable participating factors (including tissue factor-factor VII and cancer procoagulant) and their role in this process are discussed. The current theory on the role of coagulation in malignant disease is also discussed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1452517

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  4 in total

1.  Fulminant disseminated intravascular coagulation revealing an advanced stage IV poorly differenciated rhabdomyosarcoma.

Authors:  J L Stéphan; C Massoubre; M F Bertheas; J F Mosnier; F Freycon
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

2.  Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells.

Authors:  A K Kakkar; N R Lemoine; S R Stone; D Altieri; R C Williamson
Journal:  Clin Mol Pathol       Date:  1995-10

3.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 4.  Cancer and thrombosis: mechanisms and treatment.

Authors:  Steven R Deitcher
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.